Levetiracetam - Cas No: 102767-28-2, Chemical Name: (2s)-2-(2-oxopyrrolidin-1-yl) Butanamide, Molecular Formula: C8h14n2o2, Molecular Weight: 170.21 G/mol, Medicine Grade Antiepileptic Agent Preventing Partial Seizures And Myoclonic Seizures

Niksan Pharmaceutical is one of the leading manufacturer, supplier and exporter of the antiepileptic medication. The best antiepileptic product manufactured by Niksan Pharmaceutical is Levetiracetam. We manufacture, supply and export best quality product of Levetiracetam API along with Levetiracetam formulations.

Niksan Pharmaceutical provides best quality product of Levetiracetam in all states of India like Kerala, Punjab, Rajasthan, Telangana, Bihar, Karnataka, Jammu and Kashmir, Maharashtra, West Bengal, Uttar Pradesh, Gujarat, Delhi, Tamil Nadu, Odisha, Madhya Pradesh, Andhra Pradesh, Haryana and many other states.

Niksan Pharmaceutical is also manufacture and export large quantity of Levetiracetam products in whole globe since many years in countries like Chile, Mexico, Colombia, and Puerto Rico, Portugal, Germany, New Zealand, Dominican Republic, United States, Argentina, Austria, Panama, Romania, Ecuador, Guatemala, Uruguay, Paraguay, United Kingdom, Philippines, Spain, Canada, Jordan, Ireland, Australia, Netherlands, United Arab Emirates, Italy, Pakistan, Slovakia, Switzerland, Sweden, Venezuela, Singapore, Iraq, Hungary, Peru, Bolivia, Saudi Arabia, Denmark, Poland, France, Malaysia, Taiwan, South Korea, Israel, Finland, Czechia, Egypt, Hong Kong, Belgium, Thailand, Brazil, Greece, Iran, South Africa, Vietnam, Indonesia, Turkey, Japan and many other countries.

Levetiracetam is one type of antiepileptic agent which is used to prevent partial seizure in adults and also used in children.
Levetiracetam come in the category of anticonvulsant class of drug which is used in seizures.
Levetiracetam prevents seizure by inhibiting the excitement level of brain. Levetiracetam used to prevent many type of seizure like partial seizures, myoclonic seizures, epilepsies etc.

SYNONYMS OF LEVETIRACETAM: levetiracetam, levetiracetame, levetiracetamum.

IUPAC NAME: (2S)-2-(2-oxopyrrolidin-1-yl) butanamide

CAS NO: 102767-28-2

MOLECULAR FORMULA: C8H14N2O2

MOLECULAR MASS: 170.21 g/mol

STORAGE CONDITIONS OF LEVETIRACETAM: Store the Levetiracetam medication in a cool and dry place away from the direct sunlight or flames. Do not put medication in kitchen or bathroom. Keep medication in its original container. Keep medicines away from reach of pets and children.

HOW TO USE: Levetiracetam comes in tablet form. Take medications advised by your doctor, take medicine 2 times per day with or without food. Take medication regularly for the better result, dona t miss the dose and if missed the dose take it when you remember.

PHARMACOKINEICS OF LEVETIRACETAM: Levetiracetam have bioavailability of 100% in the body. Levetiracetam rapidly and completely absorbed with the oral administration. The time taken by Levetiracetam to reach the peak plasma concentration is 1-1.5 hrs. The approx. half-life of Levetiracetam is 6-8 hrs. Normally 66% of Levetiracetam and residues will excrete by urination.

SIDE EFFECTS OF LEVETIRACETAM: The common side effects of Levetiracetam are dizziness, weakness, tiredness, drowsiness, headache are seen in the patient. Tell your doctor immediately if you find symptoms like mood change, loos of coordination, suicidal thoughts, fever, chills, our throat, unusual behaviour. There are some rare allergic reactions also caused by Levetiracetam in patient like rash, itching, swelling of throat/tongue etc.

PRECAUTIONS OF LEVETIRACETAM: Tell your doctor if you have diagnosed with any kidney, heart problem or any mental disorders like depression. The drug will make you dizzy and because blurred vision so do not try to drive car or operate vehicles. Dona t do any exercise or heavy lifting. The drug cause dizziness so does not take any alcoholic product or cannabis. Always take medication on time, on a regular interval.

CDSCO APPROVAL: Levetiracetam SR Tablet 500/750/1000mg tablets approved by CDSCO in India in 20.05.2009,
Levetiracetam Tablet (addl. indication) approved by CDSCO in India in 09.10.2007,
Levetiracetam (1000mg) tablets approved by CDSCO in Indian in may 2005, Levetiracetam Oral Solution (100mg/ml) approved by CDSCO in India in 24.02.2006,
Levetiracetam (250mg, 500mg, and 750 mg) tablets approved by CDSCO in India in 05/04/2005, Levetiracetam Oral Solution 100mg/ml (Additional Indication) approved CDSCO in Indian in 05.05.2011,
Levetiracetam Oral Solution (100mg/ml) approved by CDSCO in India in 04.10.2005.

FORMULATIONS AVAILABLE IN MARKET:
Levetiracetam 250mg tablets
Levetiracetam 500mg tablets
Levetiracetam 750mg tablets
Levetiracetam SR 500mg tablets
Levetiracetam SR 750mg tablets
Levetiracetam SR 1000mg tablets
Levetiracetam Tablet (addl. indication)
Levetiracetam Oral Solution (100mg/ml)
Levetiracetam Oral solution (500mg/ml)
Levetiracetam 500mg +NACL 750 mg/ml oral solution

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk

REFERENCES:


https://pubchem.ncbi.nlm.nih.gov


https://www.wikipedia.org/